Genomic series have observed no significant differences in the prevalence of common colorectal cancer-associated mutations, such as APC, KRAS, PIK3CA and TP53, in octogenarians compared with younger colorectal cancer patients [30,31,32]. This evidence concerns the gene TP53 and colorectal cancer.